Related by context. All words. (Click for frequent words.) 67 small molecule activators 65 Hsp# inhibition 65 pharmacological chaperone 64 underlying pathophysiology 64 vascular disrupting agents 64 siRNA therapeutics 64 p# inhibitor 64 DCVax R 63 pharmacologic intervention 63 Squalamine 63 treating neuropathic pain 63 siRNA therapeutic 63 immunodeficiency disorders 63 HCV protease inhibitors 63 therapies 63 immunotherapeutic vaccine 63 HSP# inhibitor 63 imatinib resistance 63 isoform selective 63 immune modulating 63 anti angiogenic agents 63 adipose derived stem cell 63 JAK2 inhibitor 63 sd rxRNA 62 thetreatment 62 fibrotic disease 62 systemic RNAi 62 Ataluren 62 anticancer therapeutics 62 diagnostic biomarker 62 angiogenesis inhibition 62 anti angiogenic therapy 62 targeted radiotherapeutic 62 antiplatelet therapies 62 therapeutic monoclonal antibody 62 Interferon beta 62 rxRNA ™ compounds 62 Theranostics 62 selective kinase inhibitors 62 haematological cancers 62 therapeutic armamentarium 62 genomic biomarker 62 cellular immunotherapy 62 Smac mimetics 62 EP #R 62 regenerative therapy 62 prognostic markers 62 immunotoxin 62 RNAi therapeutic targeting 62 kidney urologic 62 immunotherapeutics 62 druggable 62 MyVax ® 62 immune modulator 61 OHR/AVR# 61 humanized monoclonal antibodies 61 mimetics 61 Factor VIIa 61 targeting CD# 61 hypoxic tumors 61 monoclonal antibody therapeutics 61 VDAs 61 Photodynamic therapy PDT 61 neuroprotectant 61 Anticalins ® 61 MEK inhibitors 61 histone deacetylase inhibitors 61 immunomodulatory properties 61 engineered RAP peptides 61 immuno modulatory 61 riociguat 61 antiangiogenic therapy 61 CGEN # 61 proteasome inhibitors 61 kinase inhibition 61 NovaBay Aganocide compounds 61 exon skipping 61 targeting PCSK9 61 Gleevec resistant 61 Pancreate ™ 61 ATTR CM 61 Enkephalin 61 Trofex 61 Photodynamic therapy 61 ddRNAi 61 cognitive enhancer 61 immunoregulatory 61 Xanafide 61 NPRL2 61 biomarker assay 61 pharmacologic approaches 61 personalized immunotherapy 61 LSI #P 60 NTDDS 60 PEGylated interferon 60 selective HDAC inhibitors 60 Liposomal 60 anti tubercular 60 Umbilical cord stem cells 60 molecular biomarkers 60 biomarker identification 60 molecularly targeted therapy 60 PROCHYMAL 60 predictive biomarkers 60 nanoviricide 60 ATL# [002] 60 Anavex #-# 60 biomarker assays 60 Prognostic factors 60 molecularly targeted 60 Surgical resection 60 mTOR inhibitors 60 OXIGON TM 60 choroidal vasculopathy 60 Bezielle 60 LPLD 60 targeted antifolate 60 oral prodrug 60 tkRNAi technology 60 small molecule tyrosine 60 neurotrophic 60 opioid antagonists 60 medically refractory 60 proliferative disorders 60 humanised monoclonal antibody 60 acadesine 60 NOD mouse 60 inhibit metastasis 60 CRLX# 60 molecularly targeted therapies 60 rxRNA 60 QTinno TM 60 novel immunotherapeutic 60 radioimmunotherapy RIT 60 PARP inhibitors 60 multitargeted 60 anti fibrotic 60 Personalized Immunotherapy 60 antiproliferative effects 60 VEGF inhibitors 60 histone deacetylase inhibitor 60 chemosensitivity 60 cMET 60 sJIA 60 Kinase inhibitors 60 anti angiogenic drugs 60 selective inhibition 60 Aviptadil 60 oncolytic virus 60 Lisofylline 60 neuro degenerative diseases 60 vivo validation 60 mGluR2 NAM 60 Mutation Analysis 60 vascular thrombosis 60 acetonide FA 60 cytoprotective 60 lysosomal storage diseases 60 interventional therapies 60 antisense inhibitors 60 anti infective treatments 60 prognostic indicators 60 Mipomersen 60 JAK3 60 Nick Leschly 60 BrachySil TM 60 therapeutic radiopharmaceuticals 60 NurOwn 60 iPSC 60 PLX cells 60 CYT# potent vascular disrupting 60 prognostic indicator 60 TNF alpha antagonist 60 radiation sensitizer 59 ALN TTR 59 prognostic biomarkers 59 HSP# inhibitors 59 CCX# 59 uricase 59 demethylating agent 59 chronic thromboembolic pulmonary 59 SGLT2 inhibitors 59 humanized monoclonal 59 orally bioavailable 59 CBLC# 59 theranostic 59 aerosolized KL4 surfactant 59 Deforolimus 59 mGluR5 antagonist 59 galectin 59 virotherapy 59 Bone marrow transplantation 59 ZFP TF 59 murine models 59 immunosuppressant therapies 59 IAP inhibitors 59 Hedgehog inhibitor 59 curative therapy 59 neuro stimulation 59 Interferon alpha 59 cartilage regeneration 59 OncoVEX 59 P#X# 59 PI3K inhibitors 59 radioprotective 59 VitiGam 59 prognostic marker 59 Revimmune 59 Neogenix 59 oncolytic 59 renin inhibition 59 busulfan 59 DXL# 59 pharmacogenetic testing 59 Symadex 59 AFRS TM 59 Referenced EEG 59 mGlu2 3 59 SERCA2a 59 GRN# 59 2DG 59 Litx 59 Myoblast Program 59 GEMS TM 59 BRAF inhibitors 59 chronic myocardial ischemia 59 multimodality imaging 59 selective modulator 59 DOS# 59 novel peptide 59 AAV vectors 59 cilengitide 59 anticoagulant reversing agent 59 KL4 Surfactant 59 LNP formulations 59 Radioimmunotherapy 59 Bendavia 59 allogeneic cell 59 antagomirs 59 PKC# 59 epithelial tumors 59 underlying molecular mechanisms 59 NP2 Enkephalin 59 Alequel 59 OvaRex R 59 preclinically 59 HuLuc# 59 tumor antigen 59 mTOR inhibition 59 Src inhibitors 59 stratifying patients 59 efficacious treatments 59 Cyclosert 59 sirtuin therapeutics 59 rBChE 59 Guanilib 59 Islet transplantation 59 peptide conjugated 59 vidofludimus 59 myelofibrosis polycythemia vera 59 Inhaled nitric oxide 59 pediatric malignancies 59 diagnostic modality 59 lung fibrosis 59 ANTISENILIN ® 59 Hemopurifier ® 59 HDL Selective Delipidation 59 lipid nanoparticles 59 endocrine therapies 59 Adnectin 59 phenotypic expression 59 theranostics 59 humanized antibody 59 metabonomics 59 Regado 59 novel therapeutic antibodies 59 rxRNA TM compounds 59 vascular disrupting agent 59 biologic therapies 59 CVBT #H 59 ALK inhibitors 59 myeloproliferative diseases 59 Sphingomab 59 Curaxin 59 antiangiogenic agent 59 metaglidasen 59 novel RNAi therapeutics 59 PNP inhibitor 59 BiTE 59 pathogenic mechanisms 59 antiangiogenic agents 59 #ME# 59 gastric carcinomas 59 Autoimmune diseases 58 imexon 58 EGFR inhibitors 58 telomerase activator 58 druggable targets 58 either acutely decompensated 58 cardiometabolic disorders 58 Multimeric 58 RhuDex ® 58 protein biosynthesis 58 vascular insufficiency 58 PDGF receptor 58 Dual Opioid TM 58 Fc fusion protein 58 antithrombotic therapy 58 HeliScope Sequencer 58 Electronic Brachytherapy 58 anti CD3 58 XP #L 58 immunomodulatory therapy 58 AMPK activators 58 recombinant enzyme 58 Pertuzumab 58 predictive biomarker 58 pan HDAC inhibitor 58 therapeutic modalities 58 Vidaza azacitidine 58 GPCR targets 58 ARIKACE ™ 58 PORxin TM 58 lipid lowering therapies 58 adenosine receptor 58 antithrombotic agents 58 Bioaccelerate compounds under 58 Anticalins R 58 putative biomarkers 58 immunosuppressive therapies 58 protein misfolding diseases 58 iron chelators 58 colorectal liver metastases 58 JAK2 inhibitors 58 human antibody therapeutics 58 PI3 kinase inhibitors 58 DNA methylation markers 58 ocular inflammatory 58 biologic therapeutics 58 Epothilones 58 Induced pluripotent stem cells 58 chemopreventive agents 58 hESC derived 58 TTR amyloidosis 58 FGFR1 58 Stapled Peptides 58 malignant lymphomas 58 mda 7 58 investigational therapies 58 IgG1 antibody 58 chemopreventive agent 58 noninvasive imaging 58 CompuFlo 58 KL4 surfactant 58 Antiangiogenic 58 immunologic diseases 58 Monoclonal antibody 58 noninfectious uveitis 58 allogeneic HSCT 58 orally dosed 58 eTag assays 58 Stapled Peptide 58 BHT DNA 58 pharmacokinetic interactions 58 Aggrastat ® tirofiban hydrochloride 58 antifibrotic 58 AAV vector 58 anticancer therapies 58 myoblast therapy 58 A3 adenosine receptor 58 renin inhibitors 58 Aurora Kinase 58 immunosuppressive regimens 58 ACV1 58 receptor antagonism 58 cannabinor 58 GI motility disorders 58 mechanistic insights 58 systemic fungal infections 58 peptide therapeutics 58 PEMF therapy 58 autoantigen 58 lung cancer chemoprevention 58 constipation OIC 58 fosbretabulin 58 immunomodulation 58 Perceiva 58 pathological hallmarks 58 miRagen 58 ganaxolone 58 hESC derived cardiomyocytes 58 primary hyperparathyroidism 58 therapeutically useful 58 prostate carcinoma 58 synovial cells 58 miglustat 58 regenerative medicine therapies 58 IMA# 58 therapeutics 58 bispecific antibody 58 MMP inhibitors 58 JAK inhibitors 58 triphendiol 58 TRV# [001] 58 erythropoietic 58 therapeutic 58 neovascularisation 58 TOCOSOL 58 HepDirect prodrug 58 myelination disorders 58 immunological diseases 58 Sphingomab TM 58 subtype selective 58 preclinical efficacy 58 Camptothecin 58 peptide antigens 58 endophenotypes 58 resynchronization therapy 58 blood clotting protein 58 DermaVir 58 lupus multiple sclerosis 58 immunostimulatory effects 58 AFFiRiS 58 fibrotic disorders 58 INS# [001] 58 vitamin D analogs 58 antiviral therapeutics 58 ReN# 58 spinal metastases 58 CB2 receptor 58 immunomodulators 58 immunomodulatory agents 58 metastatic lymph nodes 58 OncoVEX GM CSF 58 Therapeutic hypothermia 58 EndoTAG TM 58 Neuradiab 58 SARMs 58 presymptomatic 58 Nanobodies 58 anemias 58 biotherapy 58 Bioral 58 Onconase 57 Rheos System 57 OnDose TM 57 GW# [003] 57 PET tracers 57 Pseudomonas aeruginosa infections 57 membranous nephropathy 57 Corgentin 57 immuno therapeutic 57 Tarvacin 57 indolent lymphomas 57 synergistic combinations 57 iroxanadine 57 immune modulatory 57 solid organ transplantation 57 curative therapies 57 antiviral therapies 57 Synageva 57 imaging modality 57 thalidomide Thalomid 57 effector function 57 immunomodulatory 57 DP b# 57 non nucleoside 57 SMT C# 57 mdx mouse 57 punctal plug delivery 57 Biomerk Tumorgrafts 57 systemic RNAi therapeutic 57 Liprotamase 57 liposomal formulation 57 immunotherapeutic approaches 57 dasatinib Sprycel 57 Protein Kinase C 57 carbohydrate compounds 57 MAXY VII 57 neuroprotection 57 pharmacological approaches 57 ADME properties 57 telomerase inhibitors 57 MyVax R 57 AVI NEUGENE 57 cathepsin K 57 myopathies 57 peptidomimetic 57 Nektar proprietary 57 vivo potency 57 PARP inhibition 57 PEGylated 57 Micromet BiTE 57 Neurodegenerative diseases 57 LHRH antagonists 57 histone deacetylase HDAC 57 nanomedicines 57 Campath alemtuzumab 57 intranasal delivery 57 tumorigenicity 57 Flt3 57 Tectin TM 57 telomerase inhibitor 57 Angiocept 57 #F FDG PET 57 LentiVector 57 PDE7 inhibitors 57 nonpharmacologic 57 TNFa 57 monogenic 57 Acute Radiation Syndrome ARS 57 beta adrenergic 57 EGFR tyrosine kinase inhibitors 57 otelixizumab 57 Cytotoxic 57 stapled peptides 57 CMV vaccine 57 nucleotide analogs 57 metastatic uveal melanoma 57 Isis antisense 57 anticholinergic agents 57 neuroinflammatory diseases 57 myasthenia gravis MG 57 Archexin 57 Myelodysplastic syndrome 57 TMS Therapy 57 radionuclide therapy 57 hormone refractory 57 EVIZON TM 57 receptor tyrosine kinase inhibitor 57 immunopathology 57 Anti VEGF 57 Bevasiranib 57 stereotactic radiation 57 antiarrhythmic drug 57 ThGRF 57 Cylene 57 developing TB4 57 pro angiogenic 57 Curaxins 57 relapsing multiple sclerosis 57 chemoresistant 57 SERMs 57 neuroregenerative 57 Daclizumab 57 anticancer therapy 57 rxRNA compounds 57 pharmacological therapies 57 atherosclerosis regression 57 small molecule activator 57 Morquio 57 oligonucleotide therapeutics 57 perfusion imaging 57 drug zotarolimus 57 diagnostic biomarkers 57 proteasome inhibitor 57 Belldegrun 57 pharmacologic 57 Micro RNAs 57 virus AAV 57 beta lactam antibiotic 57 demonstrated antitumor activity 57 K ras mutations 57 DermaVir Patch 57 molecular imaging radiopharmaceutical 57 Inc. Nasdaq NLTX 57 neurotrophic factor 57 immunotoxins 57 Chimigen 57 Inosine 57 anti amnesic 57 biased ligands 57 SomatoKine 57 therapeutic regimens 57 candidate TNFerade biologic 57 thromboembolic disease 57 oncolytic viruses 57 ALI ARDS 57 Lixivaptan 57 photodynamic 57 hematological malignancy 57 amyloid hypothesis 57 benign prostatic hypertrophy BPH 57 signal transduction inhibitors 57 Radiofrequency ablation 57 NEUGENE 57 Tarvacin Anti Viral 57 OX1 57 NPM1 mutation 57 Enzyme Replacement Therapy 57 lipid nanoparticle LNP 57 CINQUIL 57 therapeutic monoclonal antibodies 57 calcineurin inhibitors 57 CCR1 57 renoprotective 57 Angiolix 57 cardiotoxic 57 myeloproliferative disorders 57 muscular dystrophies 57 TG# [003] 57 SonoLysis 57 NMDA antagonist 57 favorable pharmacokinetic profile 57 antitumour 57 Cachexia 57 Azedra 57 oral antiplatelet 57 epilepsy Parkinson disease 57 ALN PCS 57 PSN# [001] 57 OMAPRO 57 Tarvacin TM 57 potent cytotoxic 57 JAK#/JAK# 57 AN# novel 57 ENMD # 57 tezampanel 57 velafermin 57 renal fibrosis 57 psoriasis psoriatic arthritis 57 IRX 2 57 TLR antagonist 57 NF kappaB activation 57 hereditary emphysema 57 gastric carcinoma 57 virally induced 57 NS#/#A protease 57 immatics 57 neuro protective 57 monoclonal antibody therapies 56 PPAR gamma agonists 56 neuroprotective agent 56 pulsed electromagnetic field 56 etiologic factors 56 photodisinfection 56 hypoxia inducible factor 56 protein tyrosine phosphatases 56 rheumatological 56 XL# XL# 56 Pyridorin 56 Liver transplantation 56 CB1 antagonists 56 TGF beta signaling 56 refractory angina 56 antimitotic 56 Lpathomab 56 pulmonary hypertension PH 56 orally inhaled migraine 56 prognostic biomarker 56 clonogenic 56 immuno oncology 56 cardioprotection 56 Tyrosine Kinase Inhibitor 56 LEAPS TM 56 XmAb 56 interstitial cystitis IC 56 tranilast 56 Metallophile ™ Technology 56 PI3K inhibitor 56 ON #.Na 56 Smac mimetic 56 cyclophilin inhibitors 56 antiarrhythmic 56 Venous thromboembolism 56 pathophysiological mechanisms 56 sputum cytology 56 CCR9 antagonist 56 carcinoid 56 refractory Hodgkin 56 enhanced external counterpulsation 56 Glucocorticoids 56 mutated K ras 56 Cdc7 56 enzyme inhibitors 56 Cardio Vascu Grow 56 rhIGF-I/rhIGFBP-3 56 delipidation 56 THR beta agonist 56 multiplex assay 56 Th2 cytokines 56 mTOR signaling pathway 56 essential thrombocythemia ET 56 MAGE A3 ASCI 56 CTAP# Capsules 56 #beta HSD1 56 NeuroTrans TM 56 Fabry Disease 56 Phylomer ® 56 sd rxRNA compounds 56 lentiviral vector 56 antisense oligonucleotides 56 blood clotting proteins 56 IAP inhibitor 56 systemically administered 56 VAPRISOL 56 gamma secretase inhibitors 56 novel antiviral therapeutics 56 Cardiotoxicity 56 prodrugs 56 EndoTAG TM -1 56 carbohydrate polymers 56 VEGF receptor 56 RNA antagonist 56 Panzem R NCD 56 adeno associated viruses 56 Locked Nucleic Acid LNA 56 Inhaled corticosteroids 56 RhuDex 56 ALN TTR# 56 LHRH receptor positive 56 PI3K/Akt pathway inhibitor 56 histone deacetylase HDAC inhibitors 56 Hematopoietic 56 Nanobody 56 SNT MC# 56 pathogenetic 56 Traficet EN 56 Chemokine Receptor 56 Panzem R 56 CTEPH 56 cell transplantation 56 CA9 SCAN 56 antisense therapeutics 56 castrate resistant prostate cancer 56 MediGene focuses 56 Cytolin ® 56 Diabetic Foot Ulcer 56 AGHD 56 novel immunotherapies 56 pancreatic NET 56 antimetabolite 56 PI3K delta 56 rhITF 56 photopheresis 56 ALN HTT 56 Cx# [002] 56 neuroendocrine cancers 56 vinca alkaloid 56 CXCR4 receptor 56 SSc 56 enzyme inhibitor 56 Panzem 56 oncolytic vaccine 56 lentiviral vectors 56 resolvins 56 Pervasis 56 NS4A 56 xenograft models 56 cytokine signaling 56 Li Fraumeni Syndrome 56 MTP inhibitor 56 NV1FGF 56 Viprovex TM 56 Inhaled AAT 56 diagnostic molecular imaging 56 functional mitral regurgitation 56 RhuDex R 56 flavopiridol 56 ADAMTS# 56 epigenetic therapies 56 gastric adenocarcinoma 56 cells hESCs 56 mitochondrial toxicity 56 SiMoA 56 Intravenous CP 56 prostatic tissue 56 Pimavanserin 56 c myc gene 56 Revimmune TM 56 mycosis fungoides 56 antiapoptotic 56 ZFP Therapeutic 56 ChronVac C R 56 immune modulation 56 NAGS deficiency 56 anti angiogenic agent 56 chemopreventive 56 anti restenotic 56 Chronic lymphocytic leukemia 56 reslizumab 56 Perfusion CT 56 Janus kinase 56 beta interferons 56 synthetic retinoid 56 GRNCM1 56 neuroprotective therapies 56 Annexin A5 56 delta gamma agonist 56 antitumor effect 56 hES cells 56 Tumor Necrosis Factor 56 TLK# 56 Phage Pharmaceuticals 56 adjunctive therapies 56 Akt inhibitor 56 Ceflatonin 56 Martin Nicklasson CEO 56 Amphotericin B 56 liposomal delivery 56 potent inhibitors 56 siRNA delivery 56 patientswith 56 Modrenal 56 Nanobody ® 56 EECP ® therapy 56 TLR8 56 amyloid imaging 56 EGFR inhibition 56 OMNARIS HFA 56 MELAS 56 oral anticoagulants 56 Microplasmin 56 aerosolized surfactant 56 superficial bladder cancer 56 osteoinductive 56 Fingolimod 56 CRTH2 56 intravenous immunoglobulin IVIg 56 ANCA associated 56 Mucosal 56 endogenous ligands 56 Aliskiren 56 synthetic siRNAs 56 refractory colorectal cancer 56 KRN# 56 proprietary PEGylation 56 siRNA compounds 56 HepDirect R 56 Hemospan 56 Tumour Vascular Disrupting Agent 56 TBC# 56 validating biomarkers 56 NurOwn ™ 56 antiphospholipid syndrome 56 M# rationally 56 Tyrima 56 recombinant erythropoietin 56 Erythropoietic 56 Atypical antipsychotics 56 RONDEL 56 autologous cellular immunotherapy 56 ablative therapy 56 GMX# 56 Thiovir 56 oral PTH 56 TroVax ® 56 predictive toxicology 56 selective adenosine 56 biased ligand 56 FLT3 56 beta globin gene 56 sickle cell hemoglobin 56 enzastaurin 56 pharmacotherapeutic 56 Haptoglobin 56 antitumoral 56 Alferon N 56 pathophysiologic 56 FDG PET imaging 56 stable nucleic acid 56 NS4B 56 thymidylate synthase TS 56 transplantation HCT 56 Immunotherapies 56 RONDEL ™ 56 ghrelin antagonist 56 myocardial revascularization 56 atypical hemolytic uremic syndrome 56 Huntingtons disease 56 neuro inflammatory 56 chemotherapeutic 56 Valproic acid 56 intranasal insulin product 56 HuMax TAC 56 antibody mediated 56 BMS# 56 SOD1 gene 56 Prostate Px + 56 bevacizumab Avastin ® 56 NIC5 56 psoriasis rheumatoid arthritis 56 aromatase inhibitors AIs 56 antibiofilm 56 molecular determinants 56 SYN# 56 polycythemia vera PV 56 lysosomal enzyme 56 fusion enhancers 56 elacytarabine 56 thrombotic diseases 56 ESBA# 56 albumin bound paclitaxel 56 Neurostimulation 56 thrombocytosis 56 Beta catenin pathway 56 somatostatin analogues 56 Abiraterone acetate 56 SIRT1 activators 56 Zalypsis 56 idiopathic myelofibrosis 56 conformal radiotherapy 56 MET inhibitor 56 biologic plausibility 56 topical retinoids 56 Bruton tyrosine kinase Btk 56 investigational monoclonal antibody 56 relapsed leukemia 56 AA Amyloidosis 56 siRNAs targeting 56 catalytic antioxidant compounds 56 immunomodulatory effects 56 Exelixis compounds 56 urothelial cancer 56 XTEN 56 HER2 overexpression 56 dissolving clots 55 diabetic kidney 55 tubulin inhibitor 55 biologic therapy 55 HQK 55 Diastolic Heart Failure 55 Galectin 55 interferon lambda 55 HIF 1α 55 biotherapies 55 Pentraxin 2 55 blood clot dissolver 55 Myocet 55 venomics 55 Geron telomerase 55 direct thrombin inhibitors 55 Spiegelmers ® 55 IMC #B 55 AMPAKINE 55 beta 1a 55 IL 7R 55 treat chronic sinusitis 55 antiangiogenesis 55 Tyrosine Kinase Inhibitors 55 generation purine nucleoside 55 PDE# inhibitors 55 IMC #F# 55 Safinamide 55 neuroprotective properties 55 inhibitor RG# 55 oral antiviral 55 stimulate insulin secretion 55 liver metastasis 55 BCR ABL inhibitors 55 KRAS mutation status 55 Inflammatory diseases 55 Spinal cord stimulation 55 antifolate 55 Optimata 55 neural regeneration 55 insulin analogs 55 omega interferon 55 Spiegelmer 55 MTP inhibitors 55 AKT inhibitor 55 neuronal nicotinic receptors NNRs 55 tyrosine kinase inhibitor TKI 55 nucleoside analog 55 adult mesenchymal stem 55 Therapeutic antibodies 55 radiolabeled TM# 55 LHRH agonists 55 Perforomist ™ Inhalation Solution 55 BioCart ™ System 55 EndoTAGTM 1 55 Chronic pancreatitis 55 radiation therapy SBRT 55 oral picoplatin 55 severe gastroparesis 55 mineralocorticoid receptor 55 kinase profiling 55 PNT# 55 pharmacological intervention 55 Sudhir Agrawal D.Phil 55 NNR Therapeutics 55 Pemphigus 55 antitumor immunity 55 dAbs 55 volociximab 55 LPA1 receptor 55 Radilex 55 Bisphosphonate 55 neuronal nicotinic receptor NNR 55 ProMIS TM 55 deacetylase inhibitors 55 splice variants 55 rheumatologic 55 ELACYT 55 xenograft 55 afamelanotide 55 tumor specific antigen 55 HDL Mimetic Peptide 55 administered systemically